Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
TAK-593 CAS:1005780-62-0
TAK-593
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-3091 | 25mg | 450.00 | + Add to cart |
|
| R-C-3091 | 50mg | 720.00 | + Add to cart |
|
| R-C-3091 | 100mg | 1250.00 | + Add to cart |
|
|
|
||||
Product description
TAK-593 is an oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity.Only for scientific research, not for human body.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| purity | >95% |
| Solubility | N/A |
| Cas | 1005780-62-0 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
msds----TAK-593 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
